🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, multicenter, open-label, dose escalation and dose expans...
Status
Recruiting
Location
University of California-Davis
Start Date
2024-07-08
Trial ID
NCT06046495
Treatments Being Tested
Protocol Title A Study to Evaluate ANS014004 in Combination with EGFR-TKI ...
Status
Not Yet Recruiting
Location
Memorial Sloan Kettering Cancer Center David H, Koch Center lor Cancer Care
Start Date
2026-06
Trial ID
NCT07285148
Treatments Being Tested
Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 as the First-lin...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-08-07
Trial ID
NCT06574347
Treatments Being Tested
This is a phase I, open-label, multicenter study to assess the safety, tole...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2020-08-25
Trial ID
NCT05347628
Treatments Being Tested
Efficacy and safety evaluation of PLB1004 in patients with locally advanced...
Status
Enrolling By Invitation
Location
Guangdong Provincial People's Hospital
Start Date
2023-12-01
Trial ID
NCT06281964
Treatments Being Tested
Efficacy and Safety of Vebreltinib in Combination With PLB1004 Versus Plati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06970782
Treatments Being Tested
This study is an open-label, randomized, multicenter phase II/III clinical ...
Status
Recruiting
Location
Sun Yat-Sen University Cancer Center
Start Date
2026-03-11
Trial ID
NCT07336732
Treatments Being Tested
It is a phase Ⅱ,open-label, single-line, Multiple cohorts, Multicenter stud...
Status
Active Not Recruiting
Location
Guangdong General Hospital
Start Date
2023-07-21
Trial ID
NCT06015503
Treatments Being Tested
Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 in EGFR TKI Rela...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2023-06-13
Trial ID
NCT06343064
Treatments Being Tested
Tyrosine Kinase Inhibitor (TKI) that targets Epidermal Growth Factor Recept...
Status
Not Yet Recruiting
Location
Shanghai Chest hospital
Start Date
2025-08-08
Trial ID
NCT07063329
Treatments Being Tested